Feasibility of comparative health research outcome of novel surgery in prostate cancer (ip4-chronos): statistical analysis plan for the randomised feasibility phase of the chronos study

HIGHLIGHTS

• who: Emily Day from the London, Stadium House, Wood Lane, London , RH, UK have published the paper: Feasibility of Comparative Health Research Outcome of Novel Surgery in prostate cancer (IP4-CHRONOS): statistical analysis plan for the randomised feasibility phase of the CHRONOS study, in the Journal: (JOURNAL) of 08/Oct/2019
• what: The Imperial Prostate (IP4) Comparative Health Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS) study aims to deliver level 1 evidence on outcomes following focal therapy which involves treating just the tumour rather than whole-gland surgery or radiotherapy. The aim . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.